NCT05644743View on ClinicalTrials.gov

Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
OrganoidsIntrahepatic Cholangiocarcinoma
Interventions
DEVICE

gemcitabine + cisplatin

Gemcitabine intravenous drip, day 1, 8； Cisplatin intravenous drip, day 1； 3 weeks is a cycle, and 6 cycles are used continuously.

All Listed Sponsors
lead

Chengjun Sui,MD

OTHER

NCT05644743 - Clinical Transformation of Organoid Model to Predict the Efficacy of GC in the Treatment of Intrahepatic Cholangiocarcinoma | Biotech Hunter | Biotech Hunter